Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kitagawa

Showing results (671-680 of 738) with videos related to

Pageof 74
Sort By:
Nihon Kyobu Shikkan Gakkai Zasshi|April 1, 1996
[Increased CA19-9 level in serum and bronchoalveolar lavage fluid from a patient with pulmonary tuberculosis]Y Ishiura, M Fujimura, S Minami, et al.
International Journal of Pancreatology : Official Journal of the International Association of Pancreatology|April 1, 1993
Serum pancreatic stone protein in pancreatic diseasesT Hayakawa, T Kondo, T Shibata, et al.
Digestive Diseases and Sciences|March 1, 1989
Serum insulin-like growth factor II in chronic liver diseaseT Hayakawa, T Kondo, T Shibata, et al.
Hinyokika Kiyo. Acta Urologica Japonica|August 1, 1986
[An experience of percutaneous nephro-ureterolithotomy]S Ebisuno, S Morimoto, T Yoshida, et al.
International Journal of STD & AIDS|July 31, 2012
Giant cell carcinoma causing rapidly progressive respiratory failure as the presenting feature of AIDSE Sugawara, K Yamamoto, S Umeda, et al.
No Shinkei Geka. Neurological Surgery|December 1, 1990
[Metastatic Grawitz's tumor to the cauda equina: case report]I Takahashi, T Isu, Y Iwasaki, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 1, 1987
[Mixed connective tissue disease (MCTD) with severe hypertensive pulmonary vascular disease]M Kawai, H Oda, Y Sasagawa, et al.
Oncogene|September 1, 1993
Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinaseM Kitagawa, T Okabe, H Ogino, et al.
Journal of Periodontology|January 11, 2007
Effects of endogenous and exogenous prostaglandin E2 on the proliferation and differentiation of a mouse cementoblast cell line (OCCM-30)Y Mada, M Miyauchi, H Oka, et al.
Oncology|May 1, 1995
Studies on clinicopathological features of lung cancer patients with K-ras/p53 gene alterations: comparison between younger and older groupsT Kashii, Y Mizushima, C E Lima, et al.
Pageof 74

Showing results (671-680 of 738) with videos related to

Sort By:
Pageof 74
Nihon Kyobu Shikkan Gakkai Zasshi|April 1, 1996
[Increased CA19-9 level in serum and bronchoalveolar lavage fluid from a patient with pulmonary tuberculosis]Y Ishiura, M Fujimura, S Minami, et al.
International Journal of Pancreatology : Official Journal of the International Association of Pancreatology|April 1, 1993
Serum pancreatic stone protein in pancreatic diseasesT Hayakawa, T Kondo, T Shibata, et al.
Digestive Diseases and Sciences|March 1, 1989
Serum insulin-like growth factor II in chronic liver diseaseT Hayakawa, T Kondo, T Shibata, et al.
Hinyokika Kiyo. Acta Urologica Japonica|August 1, 1986
[An experience of percutaneous nephro-ureterolithotomy]S Ebisuno, S Morimoto, T Yoshida, et al.
International Journal of STD & AIDS|July 31, 2012
Giant cell carcinoma causing rapidly progressive respiratory failure as the presenting feature of AIDSE Sugawara, K Yamamoto, S Umeda, et al.
No Shinkei Geka. Neurological Surgery|December 1, 1990
[Metastatic Grawitz's tumor to the cauda equina: case report]I Takahashi, T Isu, Y Iwasaki, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 1, 1987
[Mixed connective tissue disease (MCTD) with severe hypertensive pulmonary vascular disease]M Kawai, H Oda, Y Sasagawa, et al.
Oncogene|September 1, 1993
Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinaseM Kitagawa, T Okabe, H Ogino, et al.
Journal of Periodontology|January 11, 2007
Effects of endogenous and exogenous prostaglandin E2 on the proliferation and differentiation of a mouse cementoblast cell line (OCCM-30)Y Mada, M Miyauchi, H Oka, et al.
Oncology|May 1, 1995
Studies on clinicopathological features of lung cancer patients with K-ras/p53 gene alterations: comparison between younger and older groupsT Kashii, Y Mizushima, C E Lima, et al.
Pageof 74